Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】新規3―置換セフェム化合物及びその製造方法
Document Type and Number:
Japanese Patent JPH0733389
Kind Code:
B2
Abstract:
PCT No. PCT/KR91/00012 Sec. 371 Date Feb. 26, 1992 Sec. 102(e) Date Feb. 26, 1992 PCT Filed Apr. 19, 1991 PCT Pub. No. WO92/00981 PCT Pub. Date Jan. 23, 1992.The present invention relates to novel cephalosporins of the formula (I); (I) wherein, R1 represents a C1 DIFFERENCE C4 alkyl group or wherein, R2 and R3, independently, represent hydrogen or a C1 DIFFERENCE C3 alkyl group and R4 represents hydrogen or a C1 DIFFERENCE C4 alkyl group; R1a represents hydrogen or an amino-protecting group; Q represents CH or N; and the formula represents a saturated or unsaturated heterocyclic group which contains 1 to 4 nitrogen atoms of which one is substituted with an amino group to form quaternary ammonium, and oxygen or sulfur, or a fused heterocyclic group thereof formed together with a substituted or unsubstituted benzene or an optional heterocyclic group, or a pharmaceutically acceptable salt thereof, to processes for preparing the same and to a pharmaceutical composition containing the same as an active ingredient. The compounds(1) according to the invention exhibit potent antibacterial activity and broad antibacterial spectrum against the Gram-positive strains including Staphylococcus as well as Gram-negative strains including Pseudomonas, and, therefore, are expected to be very useful in treatment of various diseases caused by bacterial infection in human beings and animals.

Inventors:
MUN CHI ZAN
PAKU SEE CHOON
KIMU MYON GUU
OO SHII HAN
IMU SON SUU
PAKU NAMU JUN
CHOI YAN KEI
SAN MUU ZE
Application Number:
JP50755691A
Publication Date:
April 12, 1995
Filing Date:
April 19, 1991
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DEE UN PHARM CO LTD
International Classes:
A61K31/545; A61K31/546; A61P31/04; C07D501/00; C07D501/04; C07D501/06; C07D501/46; (IPC1-7): C07D501/46; A61K31/545; C07D501/04; C07D501/06
Attorney, Agent or Firm:
Takashima Hajime